Post by PressReleaseon Jun 05, 2023 7:01am
142 Views
Post# 35479874
New Press Release - Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate